Moringa Acquisition Cor-CW26MACAWPreferred / convertible
13F holders, Q1 2026 (March 31)1holders
0new positions
0sold out
$0.02avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Moringa Acquisition Cor-CW26 (MACAW) in their 13F filings, unchanged from Q4 2025. 0 opened new positions and 0 sold out. The largest holder was Captrust Financial Advisors ($203).
- Company
- Moringa Acquisition Cor-CW26
- Filed as
- SILEXION THERAPEUTICS CORP WT EXP 081529 (Q1 2026)
- CUSIP
- G6S23K124
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| Captrust Financial Advisors | — | No change | 10,000 | $203 |
"% of holder's portfolio" is MACAW's weight in each manager's 13F, not the share of Moringa Acquisition Cor-CW26 the manager owns.